학술논문

Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
Document Type
article
Source
Journal of Thrombosis and Thrombolysis. 53(1)
Subject
Pharmacology and Pharmaceutical Sciences
Biomedical and Clinical Sciences
Clinical Research
Heart Disease
Heart Disease - Coronary Heart Disease
Cardiovascular
Atherosclerosis
Blood Platelets
Clopidogrel
Humans
Lipoprotein(a)
Percutaneous Coronary Intervention
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Function Tests
Ticagrelor
Ticlopidine
Platelet reactivity
Dual antiplatelet therapy
Coronary arterial disease
Percutaneous coronary intervention
Riscfactor
Clinical Sciences
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Clinical sciences
Language
Abstract
Lipoprotein(a) [Lp(a)] is an independent, genetically determined, and causal risk factor for cardiovascular disease. Laboratory data have suggested an interaction of Lp(a) with platelet function, potentially caused by its interaction with platelet receptors. So far, the potential association of Lp(a) with platelet activation and reactivity has not been proven in larger clinical cohorts. This study analyzed intrinsic platelet reactivity before loading with clopidogrel 600 mg and on-treatment platelet reactivity tested 24 h following loading in patients undergoing elective coronary angiography. Platelet reactivity was tested by optical aggregometry following stimulation with collagen or adenosine diphosphate as well as by flow cytometry. Lp(a) levels were directly measured in all patients from fresh samples. The present analysis included 1912 patients. Lp(a) levels ranged between 0 and 332 mg/dl. There was a significant association of rising levels of Lp(a) with a higher prevalence of a history of ischemic heart disease (p